Skip to main content
Figure 4 | Molecular Cancer

Figure 4

From: DNA methylation profiling of ovarian carcinomas and their in vitro models identifies HOXA9, HOXB5, SCGB3A1, and CRABP1 as novel targets

Figure 4

Bisulphite sequence electropherograms. Panel a) illustrates CpG sites 9–14 from the HOXA9 bisulphite sequencing fragment in the methylated ES-2 cell line (top) and unmethylated control (bottom). Panel b) illustrates CpG sites 15–19 from the CRABP1 bisulphite sequencing fragment also from the methylated ES-2 cell line and unmethylated control. CpG sites are indicated by arrows, whereas originally Cs converted to Ts by bisulphite sequencing are underlined. For both genes, bisulphite treated normal blood was used as unmethylated control.

Back to article page